Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7

Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease

Authors Ito K, Colley T, Mercado N

Published Date September 2012 Volume 2012:7 Pages 641—652

DOI http://dx.doi.org/10.2147/COPD.S28250

Received 16 April 2012, Accepted 19 June 2012, Published 21 September 2012

Kazuhiro Ito, Thomas Colley, Nicolas Mercado

Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom

Abstract: Chronic obstructive pulmonary disease (COPD) progresses very slowly and the majority of patients are therefore elderly. COPD is characterized by an abnormal persistent inflammatory response to noxious environmental stimuli and there are increasing evidences for a close relationship between premature aging and chronic inflammatory diseases. Thus, COPD is considered to be a disease of an accelerating aging. In this review, we collected the evidence for roles of aging on pathogenesis of COPD and considered future therapeutic strategy for COPD based on this senescence hypothesis. Since calorie restriction has been proved to extend lifespan, many efforts were made to clarify the molecular mechanism of aging. Aging is defined as the progressive decline of homeostasis that occurs after the reproductive phase of life is complete, leading to an increasing risk of disease or death due to impaired DNA repair after damage by oxidative stress or telomere shortening as a result of repeated cell division. During aging, pulmonary function progressively deteriorates; innate immunity is impaired and pulmonary inflammation increases, accompanied by structural changes, such as an enlargement of airspaces. Noxious environmental gases, such as cigarette smoke, may worsen these aging-related events in the lung or accelerate aging of the lung due to reduction in anti-aging molecules and/or stimulation of aging molecules. Aging signaling are complex but conserved in divert species, such as worm, fruit fry, rodent and humans. Especially the insulin like growth factor (IGF-1) signaling was well documented. Geroprotectors are therapeutics that affect the root cause of aging and age-related diseases, and thus prolong the life-span of animals. Most of geroprotectors such as melatonin, metformin, rapamycin and resveratrol are anti-oxidant or anti-aging molecule regulators. Therefore, geroprotection for the lung might be an attractive approach for the treatment of COPD by preventing premature aging of lung.

Keywords: premature aging, COPD, lung function, oxidative stress, sirtuin, geroprotector

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia

Liao SH, Liu CH, Bastakoti BP, Suzuki N, Chang Y, Yamauchi Y, Lin FH, Wu KCW

International Journal of Nanomedicine 2015, 10:3315-3328

Published Date: 4 May 2015

Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies

Wang Z, Mu HJ, Zhang XM, Ma PK, Lian SN, Zhang FP, Chu SY, Zhang WW, Wang AP, Wang WY, Sun KX

International Journal of Nanomedicine 2015, 10:633-644

Published Date: 14 January 2015

Photothermal cancer therapy using graphitic carbon–coated magnetic particles prepared by one-pot synthesis

Lee HJ, Sanetuntikul J, Choi ES, Lee BR, Kim JH, Kim E, Shanmugam S

International Journal of Nanomedicine 2015, 10:271-282

Published Date: 30 December 2014

Clinical issues of mucus accumulation in COPD

Osadnik CR, McDonald CF, Holland AE

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:301-302

Published Date: 25 March 2014

Muscular effects of statins in the elderly female: a review

Bhardwaj S, Selvarajah S, Schneider EB

Clinical Interventions in Aging 2013, 8:47-59

Published Date: 18 January 2013

GOLD and the fixed ratio

Vestbo J

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:663-665

Published Date: 25 September 2012

Exacerbation frequency and course of COPD

Halpin DMG, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:653-661

Published Date: 21 September 2012

Correcting magnesium deficiencies may prolong life

Rowe WJ

Clinical Interventions in Aging 2012, 7:51-54

Published Date: 16 February 2012